Biology of endocannabinoid synthesis system.

[1]  T. Uyama,et al.  Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells. , 2008, Journal of biochemistry.

[2]  A. Yamashita,et al.  2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55. , 2008, Journal of biochemistry.

[3]  K. Mackie,et al.  Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei , 2008, The Journal of comparative neurology.

[4]  Isao Morishima,et al.  Expression of the Ha-ras Suppressor Family Member 5 Gene in the Maturing Rat Testis , 2008, Bioscience, biotechnology, and biochemistry.

[5]  E. D. del Giudice,et al.  A Saturated N‐Acylethanolamine Other than N‐Palmitoyl Ethanolamine with Anti‐inflammatory Properties: a Neglected Story… , 2008, Journal of neuroendocrinology.

[6]  V. Marzo,et al.  Targeting the endocannabinoid system: to enhance or reduce? , 2008, Nature Reviews Drug Discovery.

[7]  B. Cravatt,et al.  Anandamide Biosynthesis Catalyzed by the Phosphodiesterase GDE1 and Detection of Glycerophospho-N-acyl Ethanolamine Precursors in Mouse Brain* , 2008, Journal of Biological Chemistry.

[8]  L. Petrocellis,et al.  Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain , 2008, Neuroscience.

[9]  M. Elphick,et al.  Localization of N‐acyl phosphatidylethanolamine phospholipase D (NAPE‐PLD) expression in mouse brain: A new perspective on N‐acylethanolamines as neural signaling molecules , 2008, The Journal of comparative neurology.

[10]  R. Palmiter,et al.  Multiple pathways involved in the biosynthesis of anandamide , 2008, Neuropharmacology.

[11]  N. Ueda,et al.  The stimulatory effect of phosphatidylethanolamine on N-acylphosphatidylethanolamine-hydrolyzing phospholipase D (NAPE-PLD) , 2008, Neuropharmacology.

[12]  Masahiko Watanabe,et al.  Enzymatic Machinery for Endocannabinoid Biosynthesis Associated with Calcium Stores in Glutamatergic Axon Terminals , 2008, The Journal of Neuroscience.

[13]  N. Ueda,et al.  Role of the endocannabinoid system in metabolic control , 2008, Current opinion in nephrology and hypertension.

[14]  N. Ueda,et al.  Biosynthetic Pathways of the Endocannabinoid Anandamide , 2007, Chemistry & biodiversity.

[15]  Masanobu Kano,et al.  Ca2+-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities , 2007, Current Opinion in Neurobiology.

[16]  Masahiko Watanabe,et al.  Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum , 2007, The Journal of Neuroscience.

[17]  K. Smita,et al.  Anandamide: an update , 2007, Fundamental & clinical pharmacology.

[18]  N. Ueda,et al.  Discovery and Characterization of a Ca2+-independent Phosphatidylethanolamine N-Acyltransferase Generating the Anandamide Precursor and Its Congeners* , 2006, Journal of Biological Chemistry.

[19]  B. Cravatt,et al.  Endocannabinoid Biosynthesis Proceeding through Glycerophospho-N-acyl Ethanolamine and a Role for α/β-Hydrolase 4 in This Pathway* , 2006, Journal of Biological Chemistry.

[20]  Bill X. Huang,et al.  A biosynthetic pathway for anandamide , 2006, Proceedings of the National Academy of Sciences.

[21]  P. Pacher,et al.  The Endocannabinoid System as an Emerging Target of Pharmacotherapy , 2006, Pharmacological Reviews.

[22]  Saori Oka,et al.  Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. , 2006, Progress in lipid research.

[23]  H. Zhang,et al.  Fatty acid amide hydrolase deficiency limits early pregnancy events. , 2006, The Journal of clinical investigation.

[24]  T. Freund,et al.  Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses , 2006, The Journal of Neuroscience.

[25]  N. Ueda,et al.  Functional Analysis of the Purified Anandamide-generating Phospholipase D as a Member of the Metallo-β-lactamase Family* , 2006, Journal of Biological Chemistry.

[26]  Masahiko Watanabe,et al.  Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[27]  L. Cocco,et al.  Phosphoinositide-specific phospholipase C (PI-PLC) beta1 and nuclear lipid-dependent signaling. , 2006, Biochimica et biophysica acta.

[28]  M. Okada,et al.  Coordinated intracellular translocation of phosphoinositide-specific phospholipase C-delta with the cell cycle. , 2006, Biochimica et biophysica acta.

[29]  K. Mackie,et al.  Cannabinoid receptors and endocannabinoids: Evidence for new players , 2006, The AAPS Journal.

[30]  K. Mackie,et al.  Cannabinoid receptors and endocannabinoids , 2006 .

[31]  A. Saghatelian,et al.  Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. , 2006, Biochemistry.

[32]  C. Reynet,et al.  Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. , 2006, Cell metabolism.

[33]  Daniele Piomelli,et al.  Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). , 2006, CNS drug reviews.

[34]  G. Uhl,et al.  Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain , 2006, Brain Research.

[35]  T. Bisogno,et al.  Development of the first potent and specific inhibitors of endocannabinoid biosynthesis. , 2006, Biochimica et biophysica acta.

[36]  D. Cota,et al.  The emerging role of the endocannabinoid system in endocrine regulation and energy balance. , 2006, Endocrine reviews.

[37]  B. Birnir,et al.  Endogenous Unsaturated C18 N-Acylethanolamines Are Vanilloid Receptor (TRPV1) Agonists* , 2005, Journal of Biological Chemistry.

[38]  B. Barboni,et al.  Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction , 2005, Journal of Cell Science.

[39]  M. Ueno,et al.  Regional distribution and age‐dependent expression of N‐acylphosphatidylethanolamine‐hydrolyzing phospholipase D in rat brain , 2005, Journal of neurochemistry.

[40]  Masanobu Kano,et al.  Synaptically Driven Endocannabinoid Release Requires Ca2+-Assisted Metabotropic Glutamate Receptor Subtype 1 to Phospholipase C β4 Signaling Cascade in the Cerebellum , 2005, The Journal of Neuroscience.

[41]  Lawrence J Marnett,et al.  N-Acylphosphatidylethanolamine-hydrolyzing Phospholipase D Is an Important Determinant of Uterine Anandamide Levels during Implantation* , 2005, Journal of Biological Chemistry.

[42]  C. Fowler,et al.  The endocannabinoid signaling system: Pharmacological and therapeutic aspects , 2005, Pharmacology Biochemistry and Behavior.

[43]  N. Ueda,et al.  Endocannabinoid-related enzymes as drug targets with special reference to N-acylphosphatidylethanolamine-hydrolyzing phospholipase D. , 2005, Current medicinal chemistry.

[44]  D. Osei-Hyiaman,et al.  Evidence for novel cannabinoid receptors. , 2005, Pharmacology & therapeutics.

[45]  N. Ueda,et al.  Molecular Characterization of N-Acylethanolamine-hydrolyzing Acid Amidase, a Novel Member of the Choloylglycine Hydrolase Family with Structural and Functional Similarity to Acid Ceramidase* , 2005, Journal of Biological Chemistry.

[46]  O. Pellegrini,et al.  Structural basis for substrate binding, cleavage and allostery in the tRNA maturase RNase Z , 2005, Nature.

[47]  Hee-Sup Shin,et al.  Phospholipase Cβ Serves as a Coincidence Detector through Its Ca2+ Dependency for Triggering Retrograde Endocannabinoid Signal , 2005, Neuron.

[48]  D. Piomelli,et al.  The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide , 2005, Molecular Pharmacology.

[49]  M. Fabris,et al.  Stearoylethanolamide exerts anorexic effects in mice via downregulation of liver stearoyl‐coenzyme A desaturase‐1 mRNA expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  L. Petrocellis,et al.  The endocannabinoid system and its therapeutic exploitation , 2004, Nature Reviews Drug Discovery.

[51]  M. Murakami,et al.  Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D. , 2004, The Biochemical journal.

[52]  N. Ueda,et al.  Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners* , 2004, Journal of Biological Chemistry.

[53]  Gareth Williams,et al.  Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain , 2003, The Journal of cell biology.

[54]  D. Piomelli.  The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.

[55]  S. Gaetani,et al.  Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α , 2003, Nature.

[56]  M. Roberts,et al.  An Iron-dependent Bacterial Phospholipase D Reminiscent of Purple Acid Phosphatases* , 2003, The Journal of Biological Chemistry.

[57]  H. Hansen,et al.  Brain levels of N-acylethanolamine phospholipids in mice during pentylenetetrazol-induced seizure , 2003, Lipids.

[58]  H. Schmid,et al.  Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges. , 2002, Chemistry and physics of lipids.

[59]  D. Piomelli,et al.  N-Acylethanolamines in human reproductive fluids. , 2002, Chemistry and physics of lipids.

[60]  K. Fukuzawa,et al.  Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase* , 2002, The Journal of Biological Chemistry.

[61]  A. Finazzi-Agro’,et al.  Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells. , 2002, The Biochemical journal.

[62]  N. Ueda,et al.  Activation of N-acylethanolamine-releasing phospholipase D by polyamines. , 2002, Chemistry and physics of lipids.

[63]  H. Hansen,et al.  Substantial species differences in relation to formation and degradation of N-acyl-ethanolamine phospholipids in heart tissue: an enzyme activity study. , 2002, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[64]  C. Fowler,et al.  The palmitoylethanolamide family: a new class of anti-inflammatory agents? , 2002, Current medicinal chemistry.

[65]  M. Glass,et al.  CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoids. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[66]  K. Waku,et al.  Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[67]  S. Gaetani,et al.  An anorexic lipid mediator regulated by feeding , 2001, Nature.

[68]  Hiromi Daiyasu,et al.  Expansion of the zinc metallo‐hydrolase family of the β‐lactamase fold , 2001 .

[69]  N. Ueda,et al.  Marked activation of the N-acylphosphatidylethanolamine-hydrolyzing phosphodiesterase by divalent cations. , 2001, Biochimica et biophysica acta.

[70]  H. Hansen,et al.  N-Acylethanolamines and precursor phospholipids - relation to cell injury. , 2000, Chemistry and physics of lipids.

[71]  H. Schmid.  Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively? , 2000, Chemistry and physics of lipids.

[72]  K. Chapman,et al.  A rapid phospholipase D assay using zirconium precipitation of anionic substrate phospholipids: application to n-acylethanolamine formation in vitro. , 2000, Journal of lipid research.

[73]  J. Jaroszewski,et al.  Age dependent accumulation of N-acyl-ethanolamine phospholipids in ischemic rat brain. A (31)P NMR and enzyme activity study. , 2000, Journal of lipid research.

[74]  M. Farquhar,et al.  MIR16, a putative membrane glycerophosphodiester phosphodiesterase, interacts with RGS16. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[75]  H. Hansen,et al.  N‐acylphosphatidylethanolamine‐hydrolysing phospholipase D lacks the ability to transphosphatidylate , 1999, FEBS letters.

[76]  D. Piomelli,et al.  Control of pain initiation by endogenous cannabinoids , 1998, Nature.

[77]  M. Chang,et al.  N-arachidonylethanolamine (anandamide) formation from N-arachidonylphosphatidylethanolamine in rat brain membranes. , 1997, Life sciences.

[78]  Scott M. Hammond,et al.  Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization , 1997, Current Biology.

[79]  D. Piomelli,et al.  Occurrence and Biosynthesis of Endogenous Cannabinoid Precursor,N-Arachidonoyl Phosphatidylethanolamine, in Rat Brain , 1997, The Journal of Neuroscience.

[80]  A. Yamashita,et al.  Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine. , 1996, European journal of biochemistry.

[81]  A. Yamashita,et al.  Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities. , 1996, Biochemical and biophysical research communications.

[82]  M. Frohman,et al.  Phospholipase D signaling is essential for meiosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[83]  S. Hammond,et al.  Human ADP-ribosylation Factor-activated Phosphatidylcholine-specific Phospholipase D Defines a New and Highly Conserved Gene Family (*) , 1995, The Journal of Biological Chemistry.

[84]  Z. Vogel,et al.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.

[85]  J. Schwartz,et al.  Formation and inactivation of endogenous cannabinoid anandamide in central neurons , 1994, Nature.

[86]  T. Yamane,et al.  Phospholipase D fromStreptomyces antibioticus: Cloning, sequencing, expression, and relationship to other phospholipases , 1994, Applied Microbiology and Biotechnology.

[87]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[88]  K. Mackie,et al.  Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[89]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[90]  B. Scallon,et al.  Primary structure and functional activity of a phosphatidylinositol-glycan-specific phospholipase D. , 1991, Science.

[91]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[92]  H. Schmid,et al.  N-acylethanolamine phospholipid metabolism in normal and ischemic rat brain. , 1986, Biochimica et biophysica acta.

[93]  H. Schmid,et al.  Properties of canine myocardial phosphatidylethanolamine N-acyltransferase. , 1984, Biochimica et biophysica acta.

[94]  P. C. Schmid,et al.  Catabolism of N‐Acylethanolamine Phospholipids by Dog Brain Preparations , 1984, Journal of neurochemistry.

[95]  P. C. Schmid,et al.  Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type. , 1983, The Journal of biological chemistry.

[96]  P. Majerus,et al.  Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate. , 1983, The Journal of biological chemistry.

[97]  P. C. Schmid,et al.  N-Acylation of ethanolamine phospholipids in canine myocardium. , 1982, Biochimica et biophysica acta.

[98]  K. Nicolay,et al.  Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases , 2009, Neurotoxicity Research.

[99]  Balapal S Basavarajappa,et al.  Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity. , 2007, Current neuropharmacology.

[100]  V. Marzo,et al.  Endocannabinoid synthesis and degradation, and their regulation in the framework of energy balance. , 2006, Journal of endocrinological investigation.

[101]  V. Marzo.  Endocannabinoids: synthesis and degradation. , 2006 .

[102]  S. Cockcroft.  The latest phospholipase C, PLCeta, is implicated in neuronal function. , 2006, Trends in biochemical sciences.

[103]  D. Baker,et al.  In silico patent searching reveals a new cannabinoid receptor. , 2006, Trends in pharmacological sciences.

[104]  A. Howlett.  Cannabinoid receptor signaling. , 2005, Handbook of experimental pharmacology.

[105]  L. Aravind,et al.  An evolutionary classification of the metallo-beta-lactamase fold proteins , 1998, Silico Biol..

[106]  T. Sugiura,et al.  2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. , 1995, Biochemical and biophysical research communications.

[107]  H. Schmid,et al.  N-acylated glycerophospholipids and their derivatives. , 1990, Progress in lipid research.